loadpatents
name:-0.023736953735352
name:-0.016940116882324
name:-0.000579833984375
Liggett; Stephen B. Patent Filings

Liggett; Stephen B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liggett; Stephen B..The latest application filed is for "methods for treatment with bucindolol based on genetic targeting".

Company Profile
0.19.19
  • Liggett; Stephen B. - Tampa FL US
  • Liggett; Stephen B. - Clarksville MD
  • Liggett; Stephen B. - Baltimore MD US
  • Liggett; Stephen B. - Cincinnati OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods to reduce beta-agonist-mediated tachyphylaxis
Grant 10,927,375 - Liggett February 23, 2
2021-02-23
Methods for Treatment with Bucindolol Based on Genetic Targeting
App 20180156782 - Liggett; Stephen B. ;   et al.
2018-06-07
Methods of treating obstructive lung diseases using bitter tastants
Grant 9,579,315 - Liggett , et al. February 28, 2
2017-02-28
Methods For Treatment With Bucindolol Based On Genetic Targeting
App 20150276717 - Liggett; Stephen B. ;   et al.
2015-10-01
Methods for treatment with bucindolol based on genetic targeting
Grant 8,916,603 - Liggett , et al. December 23, 2
2014-12-23
G-protein coupled receptor kinase-5 polymorphism
Grant 8,530,160 - Dorn , et al. September 10, 2
2013-09-10
Methods Of Treating Obstructive Lung Diseases Using Bitter Tastants
App 20130131108 - Liggett; Stephen B. ;   et al.
2013-05-23
Methods For Treatment With Bucindolol Based On Genetic Targeting
App 20120289573 - Liggett; Stephen B. ;   et al.
2012-11-15
Methods for treatment with bucindolol based on genetic targeting
Grant 8,093,286 - Liggett , et al. January 10, 2
2012-01-10
Methods for treatment with bucindolol based on genetic targeting
Grant 8,080,578 - Liggett , et al. December 20, 2
2011-12-20
Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction
Grant 8,071,287 - Liggett December 6, 2
2011-12-06
G-protein Coupled Receptor Kinase-5 Polymorphism
App 20100248976 - Dorn; Gerald W. ;   et al.
2010-09-30
Full Genome Sequences Of Human Rhinovirus Strains
App 20100233677 - Liggett; Stephen B. ;   et al.
2010-09-16
Methods for treatment with bucindolol based on genetic targeting
Grant 7,678,824 - Liggett , et al. March 16, 2
2010-03-16
Heart failure assessment based on alpha-2C adrenergic receptor polymorphisms
Grant 7,642,052 - Small , et al. January 5, 2
2010-01-05
Alpha-2 adrenergic receptor polymorphisms
Grant 7,572,603 - Small , et al. August 11, 2
2009-08-11
Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction
App 20090149376 - Liggett; Stephen B.
2009-06-11
Methods for Individualizing Cardiovascular Disease Treatment Protocols Based on Beta-1 Adrenergic Receptor Haplotype
App 20090092964 - Liggett; Stephen B.
2009-04-09
Methods for Treatment with Bucindolol Based on Genetic Targeting
App 20080227844 - Liggett; Stephen B. ;   et al.
2008-09-18
Methods for Treatment with Bucindolol Based on Genetic Targeting
App 20080096982 - Liggett; Stephen B. ;   et al.
2008-04-24
Alpha-2B-adrenergic receptor polymorphisms
Grant 7,229,756 - Small , et al. June 12, 2
2007-06-12
Alpha-2A-adrenergic receptor polymorphisms
Grant 7,211,386 - Small , et al. May 1, 2
2007-05-01
Methods of cardiovascular disease assessment in an individual
App 20060292565 - Small; Kersten M. ;   et al.
2006-12-28
Methods for Treatment with Bucindolol Based on Genetic Targeting
App 20060177838 - Liggett; Stephen B. ;   et al.
2006-08-10
Alpha-2 adrenergic receptor polymorphisms
Grant 7,041,810 - Small , et al. May 9, 2
2006-05-09
Alpha-2 adrenergic receptor polymorphisms
App 20060073508 - Small; Kersten M. ;   et al.
2006-04-06
Alpha -2A-adrenergic receptor polymorphisms
App 20050074772 - Small, Kersten M. ;   et al.
2005-04-07
Variation in drug response related to polymorphisms in the .beta.2-adrenergic receptor
Grant 6,861,217 - Liggett March 1, 2
2005-03-01
Variation in drug response related to polymorphisms in .beta.2-adrenergic receptor
Grant 6,797,472 - Liggett September 28, 2
2004-09-28
Alpha-2 adrenergic receptor polymorphisms
App 20030113725 - Small, Kersten M. ;   et al.
2003-06-19
Association of beta2-adrenergic receptor haplotypes with drug response
App 20030091998 - Drysdale, Connie M. ;   et al.
2003-05-15
Association of beta2-adrenergic receptor haplotypes with drug response
App 20030039979 - Liggett, Stephen B. ;   et al.
2003-02-27
Association of beta2-adrenergic receptor haplotypes with drug response
App 20010051712 - Drysdale, Connie M. ;   et al.
2001-12-13
Company Registrations
CAGE Code4Z6R2LIGGETT, STEPHEN B STEPHEN LIGGETT

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed